C12N 2800/95
Protection of vectors from inactivation by agents such as antibodies or enzymes
Official title: Protection of vectors from inactivation by agents such as antibodies or enzymes, e.g. using polymers
C12N2800/95 (Protection of vectors from inactivation by agents such as antibodies or enzymes) appears on 17 US grants and 30 published applications in this corpus.
Search patents in C12N- Granted patents
- 17
- Published applications
- 30
- Assignees
- 16
- Inventors
- 76
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 2 | 1 |
| 2013 | 0 | 4 |
| 2014 | 4 | 2 |
| 2015 | 0 | 3 |
| 2016 | 1 | 2 |
| 2017 | 2 | 1 |
| 2018 | 1 | 1 |
| 2019 | 1 | 1 |
| 2020 | 2 | 3 |
| 2021 | 0 | 0 |
| 2022 | 2 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 4 |
| 2025 | 0 | 2 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods for improved homologous recombination and compositions thereof28 Apr 2026US 12,612,650 B2Life Technologies Corporation
- RNA containing modified nucleosides and methods of use thereof31 Oct 2023US 11,801,314 B2The Trustees of the University of Pennsylvania
- Wound healing through sirt1 overexpression20 Dec 2022US 11,529,417 B2Northwestern University
- RNA containing modified nucleosides and methods of use thereof19 Jul 2022US 11,389,547 B2The Trustees of the University of Pennsylvania
- Retroviral particles expressing Sirt1 embedded within PPCN19 May 2020US 10,653,782 B2Nortwestern University
- Compositions and methods for delivery of dna to t cells16 Jul 2026US 2026/0199516 A1Flagship Pioneering Innovations Vii, LLC
- Tolerizing Immune Modifying Nanoparticles for Overcoming the Immunogenicity of Therapeutic Vectors and Proteins4 Dec 2025US 2025/0367274 A1Cour Pharmaceuticals Development Company, Inc.
- Methods and compositions for transduction of nk cells11 Sep 2025US 2025/0283110 A1
- Dna compositions comprising modified uracil29 Aug 2024US 2024/0285805 A1Flagship Pioneering Innovations Vii, LLC
- Methods for improved homologous recombination and compositions thereof25 Jul 2024US 2024/0247286 A1Life Technologies Corporation
Most cited
By later US patents
- RNA containing modified nucleosides and methods of use thereof353US 8,278,036 B2The Trustees of the University of Pennsylvania · 2012
- RNA containing modified nucleosides and methods of use thereof230US 8,691,966 B2The Trustees of the University of Pennsylvania · 2014
- RNA containing modified nucleosides and methods of use thereof222US 8,748,089 B2The Trustees of the University of Pennsylvania · 2014
- RNA containing modified nucleosides and methods of use thereof198US 8,835,108 B2The Trustees of the University of Pennsylvania · 2014
- RNA containing modified nucleosides and methods of use thereof91US 10,232,055 B2The Trustees of the University of Pennsylvania · 2019